Home Infusion & IVIG Therapy for Neuromuscular disorders, Skin Diseases(Dermatology), Primary Immunodeficiency, Obstetrics
|
|
-
IVIG is considered more effective & safer alternative to standard therapies for treatment of CIDP.
Read More ›››
-
IVIG is preferred treatment of GBS because of convenience, availability & safety.
Read More ›››
-
Recent studies show positive results using IVIG in the treatment of Alzheimer's disease.
Read More ›››
-
The usefulness of IVIG in Dermatology is ever increasing.
Read More ›››
-
The efficacy of IVIG in Primary Immune Deficiency Syndromes is well-established.
Read More ›››
|
Breaking News
KabaFusion is now a contracted provider with United Healthcare of California (UHC) effective November 15, 2012.
United HealthCare is considered one of the largest Health Plans in the country.
|
About Us
|
Experts in Home Infusion Therapy...
|
|
KabaFusion is a national Specialty Infusion Pharmacy with locations in Southern California,
Texas and New Jersey servicing patients in
twenty-two states. KabaFusion focuses on
both chronic and acute therapies including the following:
Immunoglobulin (IV & SQ), Antibiotics, Total Parenteral
Nutrition and Enteral therapies. |
 |
|
Patients
|
Looking for a Pharmacy to Start your IVIG Treatment...
|
|
Patient care is our highest priority. We
improve the lives of our patients by integrating modern medicine
with personalized compassionate care. |
Are you currently on IVIG therapy and looking for a better
pharmacy or nursing care?
|
 |
Are you having difficulty getting your insurance company to authorize
or cover your IVIG
treatment?
|
 |
Have you recently been diagnosed with a disease that may require IVIG
treatment?
|
 |
| Or Call Us at 1·877·577·IVIG (4844)
|
|
Physicians
|
Looking for Home Infusion Services for your Patients...
|
|
At KabaFusion, our dedicated team is
uniquely qualified to work with your staff and successfully
navigate the clinical and administrative complexities that are often
associated with intravenous immunoglobulin (IVIG) therapy at
home. |
 |
